What is the potential future for stem cells in medicine?

Decades of research has allowed us to glimpse the potential of stem cells to treat disease. It is possible they will give us life-changing therapies for multiple sclerosis, type 1 diabetes, Parkinson’s disease and macular degeneration, amongst others.

What is the scope of stem cells?

Cell is functional unit of life and Stem Cell functions as a unit for tissue growth, repair and regeneration. Processes of cellular physiological to pathological alteration and contribution of stem cells to tissue and organ development and rejuvenation is pathway for understanding of life.

Why stem cell therapy is the future of medicine?

Stem cells are revolutionizing medicine because of their potential to regenerate damaged tissue that is otherwise unable to be repaired. Bone marrow transplantation is one of the most widespread uses of stem cells today, and it helps with the treatment of some cancers.

What are the risks of stem cells therapy?

The risks to research participants undergoing stem cell transplantation include tumour formation, inappropriate stem cell migration, immune rejection of transplanted stem cells, haemorrhage during neurosurgery and postoperative infection.

Is regenerative medicine a good career?

Humans are not as gifted in this area of course, but the young field of regenerative medicine promises to solve a plethora of medical problems, making it a compelling career choice for any scientist who seeks to really “make a difference.” In fact, recent breakthroughs in the creation of human induced pluripotent stem …

How do I become a regenerative medicine scientist?

Candidates holding a postgraduate degree in regenerative medicine or a basic degree in Biology, B.Sc graduates with at least one subject from the biological sciences, MBBS, B. Pharma, B.D.S., B.V. Sc. or B.E. Biotechnology graduates can also find jobs in this field.

How successful is regenerative medicine?

However, regenerative medicine does have a track record of success – albeit in a very small number of diseases. “More complex diseases such as diabetes or heart infarct will require more advanced approaches than what [is] available today in order to see a significant clinical impact.